Global Medical Imaging Market

The medical imaging industry is a diverse ecosystem spanning multiple imaging modalities, clinical applications, and competitive landscapes.

The global medical imaging equipment market was approximately $45B in 2025. At a high level, it consisted of five major modalities:

• 𝐗-𝐫𝐚𝐲: $13.5B
• 𝐔𝐥𝐭𝐫𝐚𝐬𝐨𝐮𝐧𝐝: $10.5B
• 𝐌𝐑𝐈: $8B
• 𝐂𝐓: $7B
• 𝐍𝐮𝐜𝐥𝐞𝐚𝐫 𝐈𝐦𝐚𝐠𝐢𝐧𝐠: $5B

Each modality serves a distinct set of clinical needs:

• 𝐔𝐥𝐭𝐫𝐚𝐬𝐨𝐮𝐧𝐝: spans radiology, cardiology, women’s health, point-of-care, surgery, urology, and vascular imaging.
• 𝐗-𝐫𝐚𝐲: extends beyond general radiography to orthopedics, dental imaging, mammography, and C-arms used in image-guided procedures.
• 𝐌𝐑𝐈: plays a central role in neurology, oncology, musculoskeletal imaging, and cardiovascular assessment.
• 𝐂𝐓: is widely used across oncology, cardiology, neurology, trauma, and emergency medicine.
• 𝐍𝐮𝐜𝐥𝐞𝐚𝐫 𝐈𝐦𝐚𝐠𝐢𝐧𝐠: supports oncology, cardiology, and neurology through functional and molecular imaging.

A handful of companies, including **GE HealthCare, [Philips](https://www.linkedin.com/company/philips/), [Siemens Healthineers](https://www.linkedin.com/company/siemens-healthineers/), [Fujifilm Group](https://www.linkedin.com/company/fujifilmgroup/), [Canon](https://www.linkedin.com/company/canon1/), and [United Imaging Healthcare](https://www.linkedin.com/company/united-imaging-healthcare/)**, compete across multiple modalities. Many others have built strong positions by specializing in a single technology or clinical niche.

Understanding the market through both technology and clinical application provides a clearer view of where competition, innovation, and investment are concentrated.